Effect of albumin on physical characteristics of drug particles produced by supercritical fluid technology

Powder Technology

Volumn 182, Issue 3, 2008, Pages 354-363

  Kim, Yong Ho ^a   Sioutas, Constantinos ^a   Fine, Philip ^a   Shing, Katherine S ^a  

^a University of Southern California   (United States)

Author keywords

Ipratropium bromide; Pulmonary delivery; Supercritical antisolvent; Terbutaline sulfate

Indexed keywords

AERODYNAMICS; AEROSOLS; ETHANOL; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SOLVENT EXTRACTION; SUPERCRITICAL FLUIDS;

IPRATROPIUM BROMIDE; PULMONARY DELIVERY; SUPERCRITICAL ANTISOLVENT; TERBUTALINE SULFATE;

DRUG PRODUCTS;

ALCOHOL; BOVINE SERUM ALBUMIN; IPRATROPIUM BROMIDE; N,N DIMETHYLFORMAMIDE; TERBUTALINE SULFATE;

AERODYNAMICS; AEROSOLS; DRUG PRODUCTS; ETHANOL; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SOLVENT EXTRACTION; SUPERCRITICAL FLUIDS;

AEROSOL; AIRFLOW; APPARATUS; ARTICLE; DRUG DELIVERY SYSTEM; FOOD AND DRUG ADMINISTRATION; MOLECULAR INTERACTION; PARTICLE SIZE; PHYSICAL CHEMISTRY; POWDER INHALER; SCANNING ELECTRON MICROSCOPY; SOLVENT EXTRACTION; SUPERCRITICAL FLUID;

EID: 39649085798     PISSN: 00325910     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.powtec.2007.06.008     Document Type: Article

References (44)

1. Patton J.S. Mechanisms of macromolecule absorption by the lungs. Adv. Drug Deliv. Rev. 19 (1996) 3-36
2. Zeng X.M., Martin G.P., and Marriott C. Particulate Interactions in Dry Powder Formulations for Inhalation (2001), Taylor & Francis, London 30-64
3. Crowder T.M., Rosati J.A., Schroeter J.D., Hickey A.J., and Martonen T.B. Fundamental effects of particle morphology on lung delivery: predictions of stokes' law and the particular relevance to dry powder inhaler formulation and development. Pharm. Res. 19 (2002) 239-245
4. Byron P.R. Respiratory Drug Delivery (1990), CRC Press, Florida 40-60
5. Timsina M.P., Martin G.P., Marriott C., Ganderton D., and Yianneskis M. Drug delivery to the respiratory tract using dry powder inhalers. Int. J. Pharm. 101 (1994) 1-13
6. Clark A.R. Medical aerosol inhalers: past, present, and future. Aerosol Sci. Tech. 22 (1995) 374-391
7. Agu R.U., Ugwoke M.I., Armand M., Kinget R., and Verbeke N. The lung as a route for systemic delivery of therapeutic proteins and peptides. Respir. Res. 2 (2001) 198-209
8. Smith S.J., and Bernstein J.A. In: Hickey A.J. (Ed). Therapeutic Uses of Lung Aerosols. In Inhalation Aerosols: Physical and Biologic Basis for Therapy (1996), Marcel Dekker, Inc., New York 233-269
9. Steckel H., and Müller B.W. In vitro evaluation of dry powder inhalers II: influence of carrier particle size and concentration on in vitro deposition. Int. J. Pharm. 154 (1997) 31-37
10. J.N. Staniforth, Improvements in and relating to carrier particles for use in dry powder inhalers, International patent publication (1995) WO 9511666.
11. J.N. Staniforth, Carrier particles for use in dry powder inhalers, international patent publication (1996) WO 9623485.
12. Chan H.-K., Clark A., Gonda I., Mumenthaler M., and Hsu C. Spary dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery. Pharm. Res. 14 (1997) 431-437
13. Edwards D.A., Hanes J., Caponetti G., Hrkach J., Abdelaziz B.-J., Eskew M.L., Mintzes J., Deaver D., Lotan N., and Langer R. Large porous particles for pulmonary drug delivery. Science 276 5320 (1997) 1868-1871
14. Velaga S.P., Berger R., and Carlfors J. Supercritical fluids crystallization of budesonide and flunisolide. Pharm. Res. 19 (2002) 1564-1571
15. Shekunov B.Y., Feeley J.C., Chow A.H.L., Tong H.H.Y., and York P. Aerosolisation behaviour of micronised and supercritically-processed powders. J. Aerosol Sci. 34 (2003) 553-568
16. Rehman M., Shekunov B.Y., York P., Lechuga-Ballesteros D., Miller D.P., Tan T., and Colthorpe P. Optimisation of powders for pulmonary delivery using supercritical fluid technology. Eur. J. Pharm. Sci. 22 (2004) 1-17
17. Reverchon E., and Spada A. Erythromycin micro-particles produced by supercritical fluid atomization. Powder Technol. 141 (2004) 100-108
18. Steckel H., Pichert L., and Müller B.W. Influence of process parameters in the ASES process on particle properties of budesonide for pulmonary delivery. Eur. J. Pharm. Biopharm. 57 (2004) 507-512
19. Hickey A.J., and Dunbar C.A. A new millennium for inhaler technology. Pharm. Technol. 21 (1997) 116-125
20. Subramaniam B., Rajewski R.A., and Snavely K. Pharmaceutical processing with supercritical carbon dioxide. J. Pharm. Sci. 86 (1997) 885-890
21. Sievers R.E., Karst U., Milewski P.D., Sellers S.P., Miles B.A., Schaefer J.D., Stoldt C.R., and Xu C.Y. Formation of aqueous small droplet aerosols assisted by supercritical carbon dioxide. Aerosol Sci. Technol. 30 (1999) 3-15
22. Dehghani F., and Foster N.R. Dense gas anti-solvent processes for pharmaceutical formulation. Curr. Opin. Solid State Mater. Sci. 7 (2003) 363-369
23. Shariati A., and Peters C.J. Recent developments in particle design using supercritical fluids. Curr. Opin. Solid State Mater. Sci. 7 (2003) 371-383
24. Pakes G.E., Brogden R.N., Heel R.C., Speight T.M., and Avery G.S. Ipratropium bromide: A review of its pharmacological properties and pherapeutic efficacy in asthma and chronic bronchitis. Drugs 20 (1980) 237-266
25. Popa V. Beta-adrenergic drugs. Clin. Chest Med. 7 3 (1986) 313-329
26. Hogan T.J., Geddes R., and Gonzalez E.R. An economic assessment of inhaled formoterol dry powder versus ipratropium bromide pressurized metered dose inhaler in the treatment of chronic obstructive pulmonary disease. Clin. Ther. 25 (2003) 285-297
27. Kim Y.H., and Shing K.S. Supercritical fluid-micronized ipratropium bromide for pulmonary drug delivery. Powder Technol. 182 (2008) 25-32
28. Chew N.Y.K., and Chan H.-K. Use of solid corrugated particles to enhance powder aerosol performance. Pharm. Res. 18 (2001) 1570-1577
29. Chow A.H.L., Tong H.H.Y., Chattoppadhyay P., and Shekunov B.Y. Particle engineering for pulmonary drug delivery. Pharm. Res. 24 (2007) 411-437
30. Chan H.-K., and Gonda I. Aerodynamic properties of elongated particles of cromoglycic acid. J. Aerosol Sci. 20 (1989) 157-168
31. Pathak P., Meziani M.J., Desai T., and Sun Y.-P. Formation and stabilization of ibuprofen nanoparticles in supercritical fluid processing. J. Supercrit. Fluids 37 (2006) 279-286
32. Wu H.-T., Lee M.-J., and Lin H. Nano-particles formation for pigment red 177 via a continuous supercritical anti-solvent process. J. Supercrit. Fluids 33 (2005) 173-182
33. Chattopadhyay P., and Gupta R.B. Protein nanoparticles formation by supercritical antisolvent with enhanced mass transfer. AIChE J. 48 (2002) 235-244
34. Bosquillon C., Lombry C., Preat V., and Vanbever R. Comparison of particle sizing techniques in the case of inhalation dry powders. J. Pharm. Sci. 90 (2001) 2032-2041
35. Stein S.W., Gabrio B.J., Oberreit D., Hairston P., Myrdal P.B., and Beck T.J. An evaluation of mass-weighted size distribution measurements with the model 3320 aerodynamic particle sizer. Aerosol Sci. Technol. 36 (2002) 845-854
36. Peters T.M., and Leith D. Concentration measurement and counting efficiency of the aerodynamic particle sizer 3321. J. Aerosol Sci. 34 (2003) 627-634
37. Hinds W.C. Aerosol Technology-Properties, Behavior, and Measurement of Airborne Particles. 2nd ed. (1999), John Wiley & Sons, New York 42-110
38. Angus S., Armstrong B., and de Reuck K.M. International Thermodynamic Tables of the Fluid Sate Carbon Dioxide. 1st ed (1976), Pergamon Press, New York 338
39. de Diego Y.P., Pellikaan H.C., Wubbolts F.E., Witkamp G.J., and Jansens P.J. Operating regimes and mechanism of particles formation during the precipitation of polymers using the PCA process. J. Supercrit. Fluids 35 (2005) 147-156
40. Kramer P.A. Albumin microspheres as vehicles for achieving specificity in drug delivery. J. Pharm. Sci. 63 (1974) 1646-1647
41. Gupta P.K., and Hung C.T. Albumin microspheres I: Physico-chemical characteristics. J. Microencapsul 4 (1989) 427-462
42. Zeng X.M., Martin G.P., and Marriott C. Preparation and in vitro evaluation of tetrandrine-entrapped albumin microspheres as an inhaled drug delivery system. Eur. J. Pharm. Sci. 3 (1995) 87-93
43. Bosquillon C., Lombry C., Préat V., and Vanbever R. Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. J. Control. Release 70 (2001) 329-339
44. Nir S. Van der Waals interactions between surfaces of biological interest. Prog. Surf. Sci. 8 (1976) 1-58